Building Digital Architecture to Reach New Heights: Data and Knowledge Management for Pharma 4.0

Contributed Commentary by Jon Thompson, CAI

October 11, 2024 | In early 2024, it was revealed that contract research and manufacturing organization WuXi Apptec had allegedly shared intellectual property with the Chinese government without their client’s consent. This breach of trust generated widespread concern and backlash, bringing renewed attention to the importance of proper data management and data sharing in the biotech and pharmaceutical industries. Congress responded swiftly with legislation known as the BIOSECURE Act, which passed in the House of Representatives in September.

For the broader industry, it’s a powerful reminder of how important and sensitive biotech and pharmaceutical data can be. The increasing prevalence of personalized medicine requires companies to...